特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
933864

自己免疫疾患診断の世界市場の分析:種類別・製品別・技術別・地域別の将来予測

Global Autoimmune Disease Diagnostics Market Size study, by Type, Product, Technology and Regional Forecasts 2020-2026

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
自己免疫疾患診断の世界市場の分析:種類別・製品別・技術別・地域別の将来予測
出版日: 2020年04月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の自己免疫疾患診断の市場規模は、2019年に約37億米ドルに達し、さらに2019~2026年に9.20%以上の速度で成長する、と予想されています。市場成長の背景には、自己免疫疾患 - 全身性エリテマトーデス、リウマチ性関節炎など - の有病者の増加や、バイオセンサーの有用性が高まってきたこと、自己免疫疾患に対する意識の向上といった要因があります。

当レポートでは、世界の自己免疫疾患の診断の関連市場について分析し、市場の基本構造 (バリューチェーンなど) や主な促進・抑制要因、全体的な市場規模の動向見通し (今後8年間分)、種類別・製品別・技術別および地域別の詳細動向、主要企業のプロファイル・市場シェアといった情報を取りまとめてお届けいたします。

第1章 エグゼクティブサマリー

第2章 世界の自己免疫疾患診断市場:定義と範囲

第3章 世界の自己免疫疾患診断市場:市場のダイナミクス

  • 自己免疫疾患診断市場への影響度の分析
    • 市場促進要因
    • 市場の課題
    • 市場機会

第4章 世界の自己免疫疾患診断市場:業界分析

  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 新規参入企業の脅威
    • 代替品の脅威
    • 企業間競争
    • ポーターのファイブフォース分析:将来的なアプローチ
  • PEST分析
    • 政治的要因
    • 経済的要因
    • 社会的要因
    • 技術的要因
  • 投資/導入モデル
  • アナリストの提言と結論

第5章 世界の自己免疫疾患診断市場:種類別

  • 市場の概況
  • 市場の実績値、種類別:将来性の分析
  • 市場の推定値・予測値:種類別 (金額ベース)
  • サブセグメント分析
    • 局所性自己免疫疾患診断
    • 全身性自己免疫疾患診断

第6章 世界の自己免疫疾患診断市場:製品別

  • 市場の概況
  • 市場の実績値、製品別:将来性の分析
  • 市場の推定値・予測値:製品別 (金額ベース)
  • サブセグメント分析
    • 薬物
    • 治療・モニタリング装置
    • 診断装置

第7章 世界の自己免疫疾患診断市場:技術別

  • 市場の概況
  • 市場の実績値、技術別:将来性の分析
  • 市場の推定値・予測値:技術別 (金額ベース)
  • サブセグメント分析
    • ブリッジセラピー
    • 疾患修飾性抗リウマチ薬 (DMARD)
    • 局所療法
    • 光線療法
    • 蠕虫療法
    • 遺伝子組換え技術

第8章 世界の自己免疫疾患診断市場:地域別分析

  • 自己免疫疾患診断市場:地域別の市場概況
  • 北米市場
    • 米国
    • カナダ
  • 欧州市場
    • 英国
    • ドイツ
    • その他
  • アジア太平洋地域市場
    • 中国
    • インド
    • 日本
    • その他
  • ラテンアメリカ市場
    • ブラジル
    • メキシコ
  • 他の国々の市場 (RoW)

第9章 企業情報

  • 主要市場の戦略
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Siemens Healthineers
    • Abbott Laboratories
    • Danaher Corporation
    • Bio-Rad Laboratories, Inc.
    • Grifols
    • Trinity Biotech
    • Werfen
    • HYCOR Biomedical
    • Exagen Inc.

第13章 調査方法

図表

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET
  • TABLE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 22. U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 23. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 25. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 26. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 28. UK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 31. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34. ROE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 37. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46. ROAPAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 51. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 54. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. ROLA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. ROW AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
  • FIG 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 15. NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 16. EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 17. ASIA PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 18. LATIN AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
  • FIG 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
目次

Global Autoimmune Disease Diagnostics Market is valued approximately USD 3.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.20% over the forecast period 2019-2026. The Autoimmune diseases refer to body's abnormal immune response resulting in the production of antibodies that impact or attack own cells & tissues which leads to destruction and deterioration of healthy tissues. In the present scenario, there are around 80 types of autoimmune diseases such as systematic lupus erythematosus and rheumatoid arthritis prevalent in the global scenario. The Autoimmune disease diagnostics market is primarily driven owing to a high prevalence of autoimmune diseases, escalating awareness, about autoimmune diseases, rise in the number of growth activities on autoimmune diseases and escalating utility of biosensors for autoimmune disease diagnostics. The high incidence and prevalence of autoimmune diseases is acting as a key factor in the development and growth of autoimmune disease diagnostics market. For instance: according to the American Autoimmune Related Diseases Association (AARDA), the autoimmune disease impacts around 50 million individuals residing in both urban and semi-urban provinces among which 75% are females in the United States resulting in fueling the demand and adoption of autoimmune disease diagnostics market. However, high capital requirements impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Autoimmune Disease Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high incidence & prevalence of autoimmune diseases and growth in number of research activities on autoimmune diseases. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising aging population along with use of biosensors for autoimmune disease diagnosis would create lucrative growth prospects for the Autoimmune Disease Diagnostics market across Asia-Pacific region.

Major market player included in this report are:

Thermo Fisher Scientific

Siemens Healthineers

Abbott Laboratories

Danaher Corporation

Bio-Rad Laboratories, Inc.

Grifols

Trinity Biotech

Werfen

HYCOR Biomedical

Exagen Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Localized Autoimmune Disease Diagnostic

Systemic Autoimmune Disease Diagnostic

By Product:

Drugs

Therapeutic & Monitoring Equipment

Diagnostic Equipment

By Technology:

Bridge Therapy

Disease-Modifying Antirheumatic Drugs (DMARD)

Topical Therapy

Phototherapy

Helminthic Therapy

Recombinant Technology

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 20198

Forecast period - 2020 to 2026

Target Audience of the Global Autoimmune Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Autoimmune Disease Diagnostics Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Autoimmune Disease Diagnostics Market, by Type, 2018-2026 (USD Billion)
    • 1.2.3. Autoimmune Disease Diagnostics Market, by Product, 2018-2026 (USD Billion)
    • 1.2.4. Autoimmune Disease Diagnostics Market, by Technology, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Autoimmune Disease Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Autoimmune Disease Diagnostics Market Dynamics

  • 3.1. Autoimmune Disease Diagnostics Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Autoimmune Disease Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Autoimmune Disease Diagnostics Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Autoimmune Disease Diagnostics Market by Type, Performance - Potential Analysis
  • 5.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Localized Autoimmune Disease Diagnostic
    • 5.4.2. Systemic Autoimmune Disease Diagnostic
    • 5.4.3.

Chapter 6. Global Autoimmune Disease Diagnostics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Autoimmune Disease Diagnostics Market by Product, Performance - Potential Analysis
  • 6.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Product, 2016-2026 (USD Billion)
  • 6.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Therapeutic & Monitoring Equipment
    • 6.4.3. Diagnostic Equipment

Chapter 7. Global Autoimmune Disease Diagnostics Market, by Technology

  • 7.1. Market Snapshot
  • 7.2. Global Autoimmune Disease Diagnostics Market by Technology, Performance - Potential Analysis
  • 7.3. Global Autoimmune Disease Diagnostics Market Estimates & Forecasts by Technology, 2016-2026 (USD Billion)
  • 7.4. Autoimmune Disease Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Bridge Therapy
    • 7.4.2. Disease-Modifying Antirheumatic Drugs (DMARD)
    • 7.4.3. Topical Therapy
    • 7.4.4. Phototherapy
    • 7.4.5. Helminthic Therapy
    • 7.4.6. Recombinant Technology

Chapter 8. Global Autoimmune Disease Diagnostics Market, Regional Analysis

  • 8.1. Autoimmune Disease Diagnostics Market, Regional Market Snapshot
  • 8.2. North America Autoimmune Disease Diagnostics Market
    • 8.2.1. U.S. Autoimmune Disease Diagnostics Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 8.2.1.2. Product breakdown estimates & forecasts, 2016-2026
      • 8.2.1.3. Technology breakdown estimates & forecasts, 2016-2026
    • 8.2.2. Canada Autoimmune Disease Diagnostics Market
  • 8.3. Europe Autoimmune Disease Diagnostics Market Snapshot
    • 8.3.1. U.K. Autoimmune Disease Diagnostics Market
    • 8.3.2. Germany Autoimmune Disease Diagnostics Market
    • 8.3.3. Rest of Europe Autoimmune Disease Diagnostics Market
  • 8.4. Asia-Pacific Autoimmune Disease Diagnostics Market Snapshot
    • 8.4.1. China Autoimmune Disease Diagnostics Market
    • 8.4.2. India Autoimmune Disease Diagnostics Market
    • 8.4.3. Japan Autoimmune Disease Diagnostics Market
    • 8.4.4. Rest of Asia Pacific Autoimmune Disease Diagnostics Market
  • 8.5. Latin America Autoimmune Disease Diagnostics Market Snapshot
    • 8.5.1. Brazil Autoimmune Disease Diagnostics Market
    • 8.5.2. Mexico Autoimmune Disease Diagnostics Market
  • 8.6. Rest of The World Autoimmune Disease Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Thermo Fisher Scientific
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Siemens Healthineers
    • 9.2.3. Abbott Laboratories
    • 9.2.4. Danaher Corporation
    • 9.2.5. Bio-Rad Laboratories, Inc.
    • 9.2.6. Grifols
    • 9.2.7. Trinity Biotech
    • 9.2.8. Werfen
    • 9.2.9. HYCOR Biomedical
    • 9.2.10. Exagen Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.